Shamburg News · 8-K filed Oct 7, 2026, 4:45 PM EDT

Profound Medical Expects Record Preliminary Q3 2026 Revenue of $9.8M to $10.0M

PROF · Profound Medical Corp.

  • Earnings
  • Financial statements
  • Materiality: high

On October 7, 2026, Profound Medical Corp. announced preliminary unaudited revenue for the quarter ended September 30, 2026, expected to be in the range of $9.8 million to $10.0 million. The company stated this represents year-over-year growth of approximately 85% to 89% from $5.3 million in Q3 2025 and sequential growth of approximately 292% to 300% from $2.5 million in Q2 2026. The company also expects gross margin to again exceed 70%, and it plans to report full third quarter results on November 5, 2026.

Read the filing on EDGAR ↗

Source: SEC EDGAR, Form 8-K, Item 2.02, accession 0001171843-26-006499.

Written from the filing by Shamburg Markets. Figures are as reported by the company.